Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Sun Phar 473.15 0.01
Bharti A 559.00 0.18
Bajaj Au 2890.00 3.37
H D F C 1089.00 8.80
Hind Uni 2152.00 2.12
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
Sector Watch
Economy Watch
Ambalal Sarabhai Enterprises Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
Market Lot: 1Face Value: 10ISIN Demat: INE432A01017
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Business Profile
Ambalal Sarabhai Enterprises (ASE), incorporated in 1977, is a Baroda-based pharmaceutical manufacturing company. The company has products offering in the therapeutic, bulk drugs and veterinary segments. ASE`s formulations in the therapeutic segment include anti-infective, analgesic, anti-inflammatory, nutritional, oncological, cardiovascular, gastrointestinal, and antidiabetic products to name a few. The company`s products in the bulk drug segment include Acenocoumarol, Amphotericine, Ascorbic Acid, Canrenone and Carbamazeine among others. ASE in the animal health care market offers a wide range of therapeutic and nutritional formulations for livestock, poultry and pets.
ASE also has a electronics division and it contributed Rs 180 million to the sales during the fiscal year ended March 2006.

The company exports its products to regions such as Japan, Europe, USA, Africa, and Middle East. Some of its subsidiaries include Synbiotics Ltd., Haryana Containers Ltd., Asence Inc. USA, and Mautik Exim Ltd. The company Sarabhai Zydus Animal Health Ltd. its joint venture with Zydus Cadila.

The company reported fall of 5.42% in standalone net profit on y-o-y basis to Rs 54.11 million, while total income fell 3.55% y-o-y basis to Rs 39.63 million for the quarter ended September 2013.

Future Plans
The company is in the process of major restructuring exercise of its pharmaceuticals business. It plans to focus on formulation business and to raise money through sale of land.

In Brief

Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited